title: What the SWIFT and TREVO II trials tell us about the role of endovascular therapy for acute stroke.
authors.affiliation: Department of Neurology and Rehabilitation Medicine, University of Cincinnati Neuroscience Institute, 260 Stetson St, Suite 2300, PO Box 670525, Cincinnati, OH 45267-0525, USA. joseph.broderick@uc.edu
authors.forename: Joseph P
authors.initials: JP
authors.lastname: Broderick
authors.forename: Gerhard
authors.initials: G
authors.lastname: Schroth
mesh_terms: D057510:Endovascular Procedures / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D015607:Stents; D020521:Stroke / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000379:methods*; D013927:Thrombosis / Q000628:therapy; D016896:Treatment Outcome
keywords: clinical trial; ischemic; stroke; thrombectomy; thrombolysis